# Peter C. Boldingh, Pharm.D – FDA Inspection, Jan 9, 2026

Source: https://www.keypedia.com/records/fda_inspections/peter-c-boldingh-pharmd/60f1a31a-05e1-42c8-8290-f92bfd0b18be
Source feed: FDA_Inspections

> FDA inspection 1299058 of Peter C. Boldingh, Pharm.D, January 09, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1299058
- Company Name: Peter C. Boldingh, Pharm.D
- Inspection Date: 2026-01-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/chelsea-w-lamm/d7a8dd67-dc26-4c8a-8e3c-aebc267cb775)

Company: https://www.keypedia.com/companies/peter-c-boldingh-pharmd/d5c23660-e252-49e1-95c6-f1c580c2981d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c